Market Overview

The sleep disorders market was valued at USD 25.03 billion in 2024 and is projected to grow from USD 27.54 billion in 2025 to USD 66.55 billion by 2034, exhibiting a CAGR of 10.3%. The market focuses on the diagnosis, treatment, and management of sleep-related conditions. Growth is driven by increasing prevalence, rising awareness of the importance of sleep for overall health, technological advancements in diagnostic tools and treatment options, and an aging global population.

Sleep Apnea Drives Growth Potential

Insomnia holds the largest market share given its high prevalence, with an estimated 30% of adults experiencing some form of insomnia. However, sleep apnea is expected to register the highest growth. Obstructive sleep apnea is witnessing significant expansion due to rising risk factors such as obesity and an aging population, wider availability of diagnostic tools, and growing adoption of CPAP therapy. Technological advancements in treatment and a greater focus on early detection further support the segment. Insomnia's association with comorbidities such as anxiety and depression also drives demand for effective management solutions.

Diagnostics and At-Home Testing

By product, diagnostics hold the larger market share because of the critical need for accurate identification of sleep disorders. Advanced tools such as polysomnography, actigraphy, and home sleep apnea tests contribute to segment growth. Hospitals and sleep laboratories hold the larger end-user share thanks to established infrastructure for polysomnography and specialized treatments such as CPAP therapy for sleep apnea.

Home care settings are registering a higher growth rate, driven by an increasing preference for at-home diagnostics and treatments. The availability of home sleep testing devices, portable diagnostic tools, and easy-to-use devices such as CPAP machines and auto-titrating devices has made home care a more viable option.

The therapeutics segment is expected to register a higher growth rate during the forecast period, supported by increasing use of CPAP therapy for sleep apnea, new drug formulations, a shift toward noninvasive treatments, and AI integration in therapy management.

Wearables and AI Integration

Wearable sleep monitoring devices, including smartwatches and dedicated sleep trackers, use sensors and algorithms to collect data on sleep stages, heart rate, and movement and can help detect sleep apnea. According to the National Sleep Foundation, nearly 30% of US adults use some form of wearable or mobile technology to track sleep. Integration of AI is expected to enhance early detection and treatment outcomes.

Industry activity reflects this direction. In November 2024, ResMed announced the acquisition of InHealthcare, a specialist in AI-based diagnostic tools, and in October 2024, Philips launched a new series of smart sleep devices designed to provide personalized therapy and real-time monitoring at home.

Browse In-depth Market Research Report:

https://www.polarismarketresearch.com/industry-analysis/sleep-disorder-market 

North America held the largest market in 2024, driven by high prevalence of insomnia and sleep apnea and strong healthcare infrastructure, with the US supporting widespread adoption of advanced diagnostic and therapeutic technologies. In Europe, Germany, the UK, and France lead, with high demand for sleep apnea treatments and growing adoption of home sleep testing devices and wearable technology. ResMed and Philips Healthcare specialize in sleep apnea treatment with CPAP machines, whereas Medtronic and Nihon Kohden focus on diagnostic tools and home sleep testing.

Key Players in the Sleep Disorders Market

• ResMed
• Philips Healthcare
• Medtronic
• Fisher & Paykel Healthcare
• Somnomed
• Sleep Number Corporation
• Invacare Corporation
• Nihon Kohden Corporation
• CareFusion
• Becton Dickinson
• Circadia
• Inogen
• Itamar Medical
• ProTech Sleep Solutions

Conclusion

The sleep disorders market is moving toward USD 66.55 billion by 2034, supported by demand for accurate diagnostics and effective therapy. Growth in obstructive sleep apnea care, broader use of home sleep testing, and AI-enabled wearable sleep monitoring devices show a shift toward earlier detection and convenient care, creating opportunities for suppliers that combine clinical reliability with usability.

More Trending Latest Reports By Polaris Market Research:

Marketing Automation Market

Manufacturing Operations Management Software Market

Hydrocolloids Market

Extracorporeal Membrane Oxygenation Machine Market

Concrete Repair Mortars Market

Animal Vaccines Market

Animal Vaccines Market

Hydrocolloids Market

Keytruda Market